Last updated: September 10, 2020
Sponsor: China Medical University Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Trigeminal Neuralgia
Headaches
Pain
Treatment
N/AClinical Study ID
NCT04384224
CMUH109-REC3-007
Ages > 20 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age ≥ 20 2. Occurrence of episodes of intense facial paroxysmal pain in territoryinnervated by the trigeminal nerve (VAS score ≥ 6) 3. Presence of a normal neurologicexamination 4. Neurologist confirm- Normal neuroimaging analysis 5. Duration of eachpain episode < 15 minutes
Exclusion
Exclusion Criteria:
- Patient refuse to participate 2. Psychologic instability 3. Atypical pain location (eg, no specific trigger points) 4. Anticlotting therapy 5. Secondary trigeminalneuralgia
Multiple sclerosis
Temporomandibular joint disorders
Neoplasias 6. Altered neurologic profile
Hypoesthesia
Dysesthesia
Anesthesia
Paresis 7. Association with other cranial nerve neuralgias (eg, glossopharyngealneuralgia) 8. Imagiologic alterations 9. Proposed surgical intervention
Compression of the Gasser ganglion
Micro vascular decompression
Radiofrequency rhizotomy
Study Design
Total Participants: 40
Study Start date:
July 01, 2020
Estimated Completion Date:
February 28, 2022
Study Description
Connect with a study center
China Medical University Hospital
Taichung, 404
TaiwanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.